Austrália - inglês - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - tetanus toxoid, quantity: 40 iu/ml; diphtheria toxoid, quantity: 4 iu/ml - injection, suspension - excipient ingredients: water for injections; sodium chloride; aluminium hydroxide hydrate; sodium hydroxide - vaccination of children (greater than or equal to 5 years of age) and adults who have previously received at least 3 doses of a vaccine for primary immunisation against diphtheria and tetanus. adt booster is not intended for primary immunisation against diphtheria and tetanus. use of adt booster should be scheduled in accordance with official national recommendations.

Estados Unidos - inglês - NLM (National Library of Medicine)

newton laboratories, inc. - influenza a virus (unii: r9hh0nde2e) (influenza a virus - unii:r9hh0nde2e), influenza b virus (unii: 1314jz2x6w) (influenza b virus - unii:1314jz2x6w), measles virus (unii: ht3r7c012q) (measles virus - unii:ht3r7c012q), human sputum, bordetella pertussis infected (unii: u364v64hun) (human sputum, bordetella pertussis infected - unii:u364v64hun), aconitum napellus (unii: u0nq8555jd) (aconitum napellus - unii:u0nq8555jd), aluminum oxide (unii: lmi26o6933) (aluminum oxide - unii:lmi26o6933), antimony potassium -

Filipinas - inglês - FDA (Food And Drug Administration)

n/a; importer: hipra philippines, inc.; distributor: hipra philippines, inc. - vaccination device (vet.) - spray - not applicable

União Europeia - inglês - EMA (European Medicines Agency)

merck sharp & dohme b.v.  - measles virus enders’ edmonston strain (live, attenuated), mumps virus jeryl lynn (level b) strain (live, attenuated), rubella virus wistar ra 27/3 strain (live, attenuated) - rubella; mumps; immunization; measles - vaccines - m-m-rvaxpro is indicated for simultaneous vaccination against measles, mumps, and rubella in individuals 12 months or older. for use in measles outbreaks, or for post-exposure vaccination, or for use in previously unvaccinated children older than 12 months who are in contact with susceptible pregnant women, and persons likely to be susceptible to mumps and rubella.,

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

abbvie pty ltd - levobupivacaine hydrochloride, quantity: 8.449 mg/ml (equivalent: levobupivacine, qty 7.5 mg/ml) - injection, solution - excipient ingredients: sodium hydroxide; sodium chloride; water for injections; hydrochloric acid - adults levobupivacaine is indicated in adults for: surgical anaesthesia: major: epidural (including for caesarean section), intrathecal, peripheral nerve block minor: local infiltration, oral, peribulbar block in ophthalmic surgery. pain management: continuous epidural infusion, single or multiple bolus administration for post-operative, labour or chronic pain. for continuous epidural analgesia, levobupivacaine may be administered in combination with epidural fentanyl, morphine or clonidine. children levobupivacaine is indicated in children greater than 6 months of age, for infiltration analgesia (ilioinguinal/iliohypogastric blocks). after careful consideration to alternative concentrations, the 7.5mg/ml concentration of levobupivacine may be considered for those procedures requiring a dense block with low volume. the 7.5mg/ml concentration should not be considered for paediatric use.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

abbvie pty ltd - levobupivacaine hydrochloride, quantity: 5.633 mg/ml (equivalent: levobupivacine, qty 5 mg/ml) - injection, solution - excipient ingredients: water for injections; sodium hydroxide; sodium chloride; hydrochloric acid - adults levobupivacaine is indicated in adults for: surgical anaesthesia: major: epidural (including for caesarean section), intrathecal, peripheral nerve block minor: local infiltration, oral, peribulbar block in ophthalmic surgery. pain management: continuous epidural infusion, single or multiple bolus administration for post-operative, labour or chronic pain. for continuous epidural analgesia, levobupivacaine may be administered in combination with epidural fentanyl, morphine or clonidine. children levobupivacaine is indicated in children greater than 6 months of age, for infiltration analgesia (ilioinguinal/iliohypogastric blocks). after careful consideration to alternative concentrations, the 7.5mg/ml concentration of levobupivacine may be considered for those procedures requiring a dense block with low volume. the 7.5mg/ml concentration should not be considered for paediatric use.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

abbvie pty ltd - levobupivacaine hydrochloride, quantity: 2.816 mg/ml (equivalent: levobupivacine, qty 2.5 mg/ml) - injection, solution - excipient ingredients: sodium hydroxide; hydrochloric acid; water for injections; sodium chloride - adults levobupivacaine is indicated in adults for: surgical anaesthesia: major: epidural (including for caesarean section), intrathecal, peripheral nerve block minor: local infiltration, oral, peribulbar block in ophthalmic surgery. pain management: continuous epidural infusion, single or multiple bolus administration for post-operative, labour or chronic pain. for continuous epidural analgesia, levobupivacaine may be administered in combination with epidural fentanyl, morphine or clonidine. children levobupivacaine is indicated in children greater than 6 months of age, for infiltration analgesia (ilioinguinal/iliohypogastric blocks). after careful consideration to alternative concentrations, the 7.5mg/ml concentration of levobupivacine may be considered for those procedures requiring a dense block with low volume. the 7.5mg/ml concentration should not be considered for paediatric use.

Estados Unidos - inglês - NLM (National Library of Medicine)

newton laboratories, inc. - influenza a virus (unii: r9hh0nde2e) (influenza a virus - unii:r9hh0nde2e), influenza b virus (unii: 1314jz2x6w) (influenza b virus - unii:1314jz2x6w), measles virus (unii: ht3r7c012q) (measles virus - unii:ht3r7c012q), human sputum, bordetella pertussis infected (unii: u364v64hun) (human sputum, bordetella pertussis infected - unii:u364v64hun), aconitum napellus (unii: u0nq8555jd) (aconitum napellus - unii:u0nq8555jd), aluminum oxide (unii: lmi26o6933) (aluminum oxide - unii:lmi26o6933), antimony pot - formulated for vaccination-related and viral-related symptoms such as fever, inflammation, injection site pain, fatigue and skin discomfort. formulated for vaccination-related and viral-related symptoms such as fever, inflammation, injection site pain, fatigue and skin discomfort.

Estados Unidos - inglês - NLM (National Library of Medicine)

newton laboratories, inc. - influenza a virus (unii: r9hh0nde2e) (influenza a virus - unii:r9hh0nde2e), influenza b virus (unii: 1314jz2x6w) (influenza b virus - unii:1314jz2x6w), measles virus (unii: ht3r7c012q) (measles virus - unii:ht3r7c012q), human sputum, bordetella pertussis infected (unii: u364v64hun) (human sputum, bordetella pertussis infected - unii:u364v64hun), aconitum napellus (unii: u0nq8555jd) (aconitum napellus - unii:u0nq8555jd), aluminum oxide (unii: lmi26o6933) (aluminum oxide - unii:lmi26o6933), antimony pot - formulated for vaccination-related and viral-related symptoms such as fever, inflammation, injection site pain, fatigue and skin discomfort. formulated for vaccination-related and viral-related symptoms such as fever, inflammation, injection site pain, fatigue and skin discomfort.

Estados Unidos - inglês - NLM (National Library of Medicine)

newton laboratories, inc. - influenza a virus (unii: r9hh0nde2e) (influenza a virus - unii:r9hh0nde2e), influenza b virus (unii: 1314jz2x6w) (influenza b virus - unii:1314jz2x6w), measles virus (unii: ht3r7c012q) (measles virus - unii:ht3r7c012q), human sputum, bordetella pertussis infected (unii: u364v64hun) (human sputum, bordetella pertussis infected - unii:u364v64hun), aconitum napellus (unii: u0nq8555jd) (aconitum napellus - unii:u0nq8555jd), aluminum oxide (unii: lmi26o6933) (aluminum oxide - unii:lmi26o6933), antimony pot - formulated for vaccination-related and viral-related symptoms such as fever, inflammation, injection site pain, fatigue and skin discomfort. formulated for vaccination-related and viral-related symptoms such as fever, inflammation, injection site pain, fatigue and skin discomfort.